ED
CLVS
Exane Derivatives’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $299 | Hold |
166
| – | – | ﹤0.01% | 640 |
|
|
2022
Q1 | $335 | Hold |
166
| – | – | ﹤0.01% | 910 |
|
|
2021
Q4 | $450 | Hold |
166
| – | – | ﹤0.01% | 768 |
|
|
2021
Q3 | $740 | Hold |
166
| – | – | ﹤0.01% | 876 |
|
|
2021
Q2 | $876 | Hold |
166
| – | – | ﹤0.01% | 872 |
|
|
2021
Q1 | $1.17K | Hold |
166
| – | – | ﹤0.01% | 697 |
|
|
2020
Q4 | $797 | Hold |
166
| – | – | ﹤0.01% | 683 |
|
|
2020
Q3 | $968 | Hold |
166
| – | – | ﹤0.01% | 594 |
|
|
2020
Q2 | $1.12K | Hold |
166
| – | – | ﹤0.01% | 524 |
|
|
2020
Q1 | $1.06K | Sell |
166
-1,934
| -92% | -$12.3K | ﹤0.01% | 519 |
|
|
2019
Q4 | $19.8K | Hold |
2,100
| – | – | ﹤0.01% | 377 |
|
|
2019
Q3 | $8.25K | Hold |
2,100
| – | – | ﹤0.01% | 413 |
|
|
2019
Q2 | $31.2K | Hold |
2,100
| – | – | 0.01% | 391 |
|
|
2019
Q1 | $52.1K | Hold |
2,100
| – | – | 0.01% | 318 |
|
|
2018
Q4 | $37.7K | Hold |
2,100
| – | – | 0.01% | 361 |
|
|
2018
Q3 | $61.7K | Hold |
2,100
| – | – | 0.01% | 338 |
|
|
2018
Q2 | $95.4K | Buy |
+2,100
| New | +$95.4K | 0.02% | 312 |
|